Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 121 (2) , 382-388
- https://doi.org/10.1053/gast.2001.26288
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Hemodynamic Response to Medical Treatment of Portal Hypertension As A Predictor of Clinical Effectiveness in the Primary Prophylaxis of Variceal Bleeding in CirrhosisHepatology, 2000
- Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution.Gastroenterology, 1999
- Effect of Losartan, An Angiotensin Ii Receptor Antagonist, on Portal Pressure in CirrhosisHepatology, 1999
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisPublished by Elsevier ,1995
- Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal functionGastroenterology, 1995
- Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhageGastroenterology, 1990
- Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosisGastroenterology, 1989
- Measurement of Azygos Venous Blood Flow by a Continuous Thermal Dilution Technique: An Index of Blood Flow Through Gastroesophageal Collaterals in Cirrhosis†Hepatology, 1984
- Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascitesEuropean Journal of Clinical Investigation, 1981